BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 23, 2006
View Archived Issues
Recent data on HDAC inhibitors in neurological conditions
Read More
Preclinical data on actively investigated KSP inhibitor from GSK
Read More
Gantacurium pharmacodynamics assessed in phase II trial
Read More
Study reveals phenoxodiol effects, mechanism in prostate cancer
Read More
Cobra signs CRADA with U.S. Navy for ORT-VAC based malaria vaccine
Read More
Rencarex completes phase II study in combination interferon alpha-2a
Read More
Phase II study of MF-101 for menopausal symptoms completes enrollment
Read More
Enrollment complete in first stage of phase II ALS trial of ALS-08
Read More
Auxilium discontinues TestoFilm, reallocates resources to AA-4500
Read More
NIH releases strategic plan to guide type 1 diabetes research
Read More
SIGA-246 gives 100% protection against human smallpox virus in primate trial
Read More
Positive phase III findings for Transacin in postherpetic neuralgia
Read More
Genmab updates pipeline progress and future plans
Read More
Merck KGaA and Glenmark sign agreement for DPP-IV inhibitor GRC-8200
Read More
Bayer and Regeneron to collaborate on VEGF Trap-Eye
Read More
Recent patents describe novel agents for anxiety, depression, psychosis, etc.
Read More
Recent patents disclose new antiinfective agents
Read More
Novel treatment strategies for cancer covered in recent patent literature
Read More
Compugen selects three new potential therapeutic candidates
Read More
Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity
Read More
Preclinical data on Merck's novel CB1 agonist MK-0364 reported at the SfN meeting
Read More
Differential modulation of mGluR5 activity yields therapeutic potential in CNS disorders
Read More
Seroquel SR filed for approval in Canada, E.U.
Read More
Adrovance recommended for approval in E.U.
Read More
European CHMP issues positive opinion on Diacomit submission
Read More
Tandemact recommended for approval in E.U.
Read More
Europe's CHMP recommends Hycamtin for new indication
Read More
Positive opinion handed down in Europe for new Glivec indication
Read More
Aldara recommended for approval for actinic keratosis in Europe
Read More